US Broker Ratings

Adaptive Biotechnologies Corporation (ADPT): Investor Outlook with a 102.40% Revenue Growth Potential

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) has caught the attention of investors with its impressive revenue growth of 102.40% over the past year. As a leading player in the biotechnology sector,..

The Pennant Group (PNTG) Stock Analysis: Exploring a 22.79% Upside in the Healthcare Sector

The Pennant Group, Inc. (PNTG), operating in the dynamic healthcare sector, has been gaining traction among investors, largely due to its solid growth potential and promising analyst ratings. Based in..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 63% Upside Potential in Biotech Innovation

Biohaven Ltd. (BHVN) is making waves in the biotechnology sector with its ambitious pipeline of treatments targeting neurological, psychiatric, and oncological diseases. With a market capitalization of $1.69 billion, Biohaven..

AtriCure, Inc. (ATRC) Stock Analysis: Exploring 37% Upside Potential in the Medical Instruments Sector

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, offers a compelling investment opportunity with a substantial potential upside of 37.05%, according to analyst target price projections. Headquartered..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 36% Upside Potential in the Biotechnology Sector

Edgewise Therapeutics, Inc. (NASDAQ: EWTX) is currently capturing the attention of investors with a robust potential upside of 36.21%. As a biopharmaceutical innovator in the healthcare sector, Edgewise is strategically..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 16% Potential Upside in the Diagnostics & Research Sector

NeoGenomics, Inc. (NASDAQ: NEO), a leader in the diagnostics and research industry with a specialization in cancer-focused testing laboratories, presents an intriguing opportunity for investors seeking growth in the healthcare..

Amphastar Pharmaceuticals, Inc. (AMPH) Stock Analysis: Unveiling a Potential 18.69% Upside for Investors

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a leading player in the drug manufacturing sector, particularly in specialty and generic segments, has been attracting the attention of investors with its robust product..

LivaNova PLC (LIVN) Stock Analysis: Navigating Market Growth with a 13.71% Potential Upside

LivaNova PLC (LIVN), a key player in the healthcare sector specializing in medical devices, has caught the attention of investors with its solid performance and promising future outlook. With a..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring the 17% Potential Upside for Investors

MoonLake Immunotherapeutics (NASDAQ: MLTX), a Switzerland-based biotechnology company, has captured investor attention with its ambitious focus on developing innovative therapies for inflammatory skin and joint diseases. The company’s leading candidate,..

Veracyte, Inc. (VCYT) Stock Analysis: A Diagnostic Leader with 17.49% Potential Upside

Veracyte, Inc. (VCYT), a leading player in the healthcare sector, stands out in the diagnostics and research industry with its innovative genomic tests. Headquartered in South San Francisco, Veracyte is..

AdaptHealth Corp. (AHCO) Stock Analysis: A 30% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector should take a closer look at AdaptHealth Corp. (NASDAQ: AHCO), a promising player in the medical devices industry with a market capitalization of..

Twist Bioscience Corporation (TWST) Stock Analysis: Exploring the Potential of Synthetic DNA and a Strong Buy Consensus

Investors with an eye on the healthcare sector might find Twist Bioscience Corporation (NASDAQ: TWST) an intriguing prospect. Positioned at the forefront of synthetic DNA manufacturing, Twist Bioscience boasts a..

Innoviva, Inc. (INVA): Investor Outlook Highlights 66.5% Potential Upside

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, offers intriguing prospects for investors seeking exposure in the healthcare industry. Headquartered in Burlingame, California, Innoviva is primarily engaged..

Pediatrix Medical Group, Inc. (MD) Stock Analysis: Assessing the 6.27% Potential Upside

Pediatrix Medical Group, Inc. (NYSE: MD) operates within the healthcare sector, specifically focusing on medical care facilities in the United States. With a market capitalization of $1.86 billion, the company..

Ascentage Pharma Group Internat (AAPG): Investor Outlook on a Biotech Pioneer with 78.64% Potential Upside

Ascentage Pharma Group Internat (AAPG), a clinical-stage biotechnology company based in Suzhou, China, is carving a significant niche in the healthcare sector with its innovative therapies targeting cancers, chronic hepatitis..

Artivion, Inc. (AORT) Stock Analysis: A 20% Upside Potential in the Medical Devices Sector

Artivion, Inc. (NASDAQ: AORT), a prominent player in the medical devices industry, has been capturing the attention of investors with its significant upside potential, driven by innovative products and strategic..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 9% Potential Upside in the Healthcare Sector

Investors with an eye on the healthcare sector may want to take a closer look at Azenta, Inc. (NASDAQ: AZTA), a company that specializes in providing innovative solutions for biological..

SS Innovations International (SSII) Stock Analysis: Navigating the Robotic Revolution with 192.5% Revenue Growth

Investors looking for exposure in the burgeoning field of surgical robotics should pay close attention to SS Innovations International, Inc. (SSII). Headquartered in Gurugram, India, this healthcare company is making..

Recursion Pharmaceuticals, Inc. (RXRX) Stock Analysis: Exploring a 52.51% Potential Upside in Biotech

Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) presents an intriguing opportunity for investors looking to delve into the biotechnology sector. This clinical-stage company, headquartered in Salt Lake City, Utah, is pioneering the..

ICU Medical, Inc. (ICUI) Stock Analysis: A Potential 18.3% Upside with Strong Buy Ratings

ICU Medical, Inc. (NASDAQ: ICUI) presents a compelling investment case for those eyeing the healthcare sector, particularly in the medical instruments and supplies industry. As a United States-based company with..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds